Physician

Sankar S Alagugurusamy, MD

According to 2025 Medicare claims, Sankar Alagugurusamy, MD (NPI: 1093970576) practices gastroenterology in the Mount Vernon-Anacortes, WA market, with the plurality of this provider's patient population coming from Skagit, WA. This provider's primary affiliated billing organization is PUBLIC HOSPITAL DIST NO 1 SKAGIT (NPI: 1023332749; TIN: 562392010) and primary practice location at 98274-4126. Alagugurusamy is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), Cascadia Care Network LLC (ACO ID: A3731), and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Alagugurusamy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 532 traditional Medicare patients, billed 983 HCPCS/CPT codes, and received $108,099 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,005 prescription claims across 472 beneficiaries totaling $77,333 in drug costs, led by Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates). Open Payments data shows 3 records totaling $83. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $292,392 to $77,333. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	380	791	$84,662
2016	424	880	$89,059
2017	471	1,021	$104,304
2018	38	211	$11,403
2019	N/R	N/R	N/R
2020	13	41	$2,804
2021	335	668	$69,220
2022	378	849	$81,566
2023	439	940	$99,834
2024	532	983	$108,099

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	173	450	$292,392
2016	288	705	$1,345,678
2017	272	747	$507,983
2018	101	253	$70,703
2019	65	129	$31,547
2020	104	239	$38,313
2021	167	254	$21,793
2022	258	482	$43,662
2023	323	580	$37,817
2024	472	1,005	$77,333

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	160	162	$198
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	65	65	$98
45380	Biopsy of large bowel using a flexible endoscope	90	90	$82
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	71	85	$74
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	153	158	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	217	293	$14,692
Linzess	Linaclotide	14	480	$8,600
Ursodiol	Ursodiol	28	1,020	$2,852
Omeprazole	Omeprazole	303	13,098	$2,780
Pantoprazole Sodium	Pantoprazole Sodium	96	4,529	$1,200

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$83	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sankar S. Alagugurusamy, MD?

Tedicare shows public-source Medicare data for Sankar S. Alagugurusamy, MD (NPI 1093970576), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sankar S. Alagugurusamy, MD have ACO affiliation data?

Sankar S. Alagugurusamy, MD is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342), Cascadia Care Network LLC (MSSP, ACO ID A3731), and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Sankar S. Alagugurusamy, MD?

Sankar S. Alagugurusamy, MD is linked to PUBLIC HOSPITAL DIST NO 1 SKAGIT (billing NPI 1023332749) in the available physician profile data.

Does Sankar S. Alagugurusamy, MD have Open Payments data?

Sankar S. Alagugurusamy, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.